Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC GNE-149 | 1953132-75-6 | 99.2% | C28H33F4N3O | 25 MG
SDP

Catalog No. 5000356614
Encompass_Preferred

GNE-149 is an orally bioavailable full antagonist of estrogen receptor α (ERα) and a selective estrogen receptor degrader (SERD). It can be used for breast cancer research, exhibiting antiproliferative activity in MCF7 and T47D cells, and inducing ERα degradation. It also demonstrates efficacy in an MCF7 xenograft mouse model.

  • Full antagonist of estrogen receptor α (ERα)
  • Selective estrogen receptor degrader (SERD)
  • Exhibits antiproliferative activity in MCF7 and T47D cells
  • Induces ERα degradation
  • Favorable pharmacokinetic profile with oral bioavailability in various models
  • Solid, white to light yellow appearance

Catalog No. 50-003-56614 Supplier Medchemexpress LLC Supplier No. 25MGHY145341
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

GNE-149 is an orally bioavailable full antagonist of estrogen receptor α (ERα) and a selective estrogen receptor degrader (SERD). It can be used for breast cancer research, exhibiting antiproliferative activity in MCF7 and T47D cells, and inducing ERα degradation. It also demonstrates efficacy in an MCF7 xenograft mouse model.

  • Full antagonist of estrogen receptor α (ERα)
  • Selective estrogen receptor degrader (SERD)
  • Exhibits antiproliferative activity in MCF7 and T47D cells
  • Induces ERα degradation
  • Favorable pharmacokinetic profile with oral bioavailability in various models
  • Solid, white to light yellow appearance

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.